BAP1 Gene

Last updated on: 23.08.2024

Dieser Artikel auf Deutsch

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

The BAP1 gene (BAP1 stands for "BRCA1-associated protein 1") is a protein-coding gene located on chromosome 3p21.1. The BAP1 gene belongs to the ubiquitin C-terminal hydrolase subfamily, which is involved in the removal of ubiquitin from proteins. The encoded enzyme , is a deubiquitylase, binds to BRCA1 (breast cancer type 1 susceptibility protein) through its RING finger domain and acts as a tumor suppressor. In addition, the enzyme may be involved in the regulation of transcription, cell cycle and growth, DNA damage response, and chromatin dynamics. Deubiquitylase BAP1 is an important regulator of many cancer-associated signaling pathways. It is a deubiquitinating enzyme that plays a key role in chromatin by mediating the deubiquitination of histone H2A and HCFC1 (Okino Y et al. 2015).Furthermore, the enzyme acts as a regulator of cell growth by mediating the deubiquitination of N-terminal and C-terminal HCFC1 chains, with some specificity toward 'Lys-48'-linked polyubiquitin chains compared to 'Lys-63'-linked polyubiquitin chains (Machida YJ et al. 2009).

Clinical pictureThis section has been translated automatically.

Germline mutations in this gene may be associated with tumor predisposition syndrome (TPDS), which involves an increased risk of cancers such as malignant mesothelioma, uveal melanoma and cutaneous melanoma.

Diseases associated with BAP1 include:

and

LiteratureThis section has been translated automatically.

  1. Battaglia A (2014) The importance of multidisciplinary approach in early detection of BAP1 tumor predisposition syndrome: clinical management and risk assessment. Clin Med Insights Oncol 8:37-47.
  2. Brown A et al. (2021) Spitz Nevus: Review and Update. Clin Plast Surg 48:677-686.
  3. Carbone M et al. (2012) BAP1 cancer syndrome: malignant mesothelioma, uveal and cutaneous melanoma, and MBAITs. J Transl Med10:179.
  4. de la Fouchardière A et al. (2015) Germline BAP1 mutations also predispose to multiple basal cell carcinomas. Clin Genet 88:273-237.
  5. Kury, S et al.( 2022) Rare germline heterozygous missense variants in BRCA1-associated protein 1, BAP1, cause a syndromic neurodevelopmental disorder. Am J Hum Genet 109: 361-372.
  6. Machida YJ et al. (2009) The deubiquitinating enzyme BAP1 regulates cell growth via interaction with HCF-1. J Biol Chem 284:34179-3488.
  7. Okino Y et al. (2015) BRCA1-associated protein 1 (BAP1) deubiquitinase antagonizes the ubiquitin-mediated activation of FoxK2 target genes. J Biol Chem 290:1580-1591.
  8. Rai K et al. (2017) Germline BAP1 alterations in familial uveal melanoma. Genes Chromosomes Cancer 56:168-174.
  9. Wiesner T et al. (2011) Germline mutations in BAP1 predispose to melanocytic tumors. Nat Genet 43: 1018-1021.

  10. Wiesner T et al. (2016) Genomic aberrations in spitzoid melanocytic tumors and their implications for diagnosis, prognosis and therapy. Pathology 48:113-131.

Last updated on: 23.08.2024